OpenURL Connection Search

Select item for more details and to access through your institution.

Natural history of liver‐related disease in patients with chronic hepatitis C virus infection: An analysis using a Markov chain model.
Published in:
Journal of Medical Virology, 2019, v. 91, n. 10, p. 1837, doi. 10.1002/jmv.25533
By:
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Yasuda, Satoshi;
- Miyake, Nozomi;
- Kumada, Takashi;
- Kurisu, Akemi;
- Ohisa, Masayuki;
- Akita, Tomoyuki;
- Tanaka, Junko
Publication type:
Article
Abnormal fucosylation of alpha‐fetoprotein in patients with nonalcoholic steatohepatitis.
Published in:
Hepatology Research, 2021, v. 51, n. 5, p. 548, doi. 10.1111/hepr.13626
By:
- Nouso, Kazuhiro;
- Furubayashi, Yoshie;
- Kariyama, Kazuya;
- Wakuta, Akiko;
- Miyake, Nozomi;
- Inoue, Kanae;
- Nagai, Yuta;
- Murakami, Shiho;
- Adachi, Takuya;
- Oyama, Atsushi;
- Wada, Nozomu;
- Takeuchi, Yasuto;
- Sakata, Masahiro;
- Yasunaka, Tetsuya;
- Onishi, Hideki;
- Shiraha, Hidenori;
- Takaki, Akinobu;
- Shiota, Shohei;
- Yasuda, Satoshi;
- Toyoda, Hidenori
Publication type:
Article
Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".
Published in:
Liver International, 2024, v. 44, n. 7, p. 1736, doi. 10.1111/liv.15964
By:
- Tatsuya Kikuchi;
- Yasuto Takeuchi;
- Kazuhiro Nouso;
- Kazuya Kariyama;
- Kenji Kuwaki;
- Junichi Toshimori;
- Shota Iwado;
- Akio Moriya;
- Hiroaki Hagihara;
- Hiroyuki Takabatake;
- Toshifumi Tada;
- Tetsuya Yasunaka;
- Masahiro Sakata;
- Masahiko Sue;
- Nozomi Miyake;
- Takuya Adachi;
- Nozomu Wada;
- Hideki Onishi;
- Hidenori Shiraha;
- Akinobu Takaki
Publication type:
Article
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab.
Published in:
Liver International, 2024, v. 44, n. 6, p. 1456, doi. 10.1111/liv.15907
By:
- Kikuchi, Tatsuya;
- Takeuchi, Yasuto;
- Nouso, Kazuhiro;
- Kariyama, Kazuya;
- Kuwaki, Kenji;
- Toshimori, Junichi;
- Iwado, Shota;
- Moriya, Akio;
- Hagihara, Hiroaki;
- Takabatake, Hiroyuki;
- Tada, Toshifumi;
- Yasunaka, Tetsuya;
- Sakata, Masahiro;
- Sue, Masahiko;
- Miyake, Nozomi;
- Adachi, Takuya;
- Wada, Nozomu;
- Onishi, Hideki;
- Shiraha, Hidenori;
- Takaki, Akinobu
Publication type:
Article
Chronological change in serum albumin as a prognostic factor in patients with hepatocellular carcinoma treated with lenvatinib: proposal of albumin simplified grading based on the modified albumin–bilirubin score (ALBS grade).
Published in:
Journal of Gastroenterology, 2022, v. 57, n. 8, p. 581, doi. 10.1007/s00535-022-01883-7
By:
- Kariyama, Kazuya;
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Tsuji, Kunihiko;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Tada, Toshifumi;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Ishikawa, Toru;
- Shimada, Noritomo;
- Tsutsui, Akemi;
- Nagano, Takuya;
- Imai, Michitaka;
- Nakamura, Shinichiro;
- Wakuta, Akiko;
- Miyake, Nozomi
Publication type:
Article
Long‐term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus–related decompensated cirrhosis.
Published in:
Journal of Viral Hepatitis, 2021, v. 28, n. 3, p. 508, doi. 10.1111/jvh.13457
By:
- Kumada, Takashi;
- Toyoda, Hidenori;
- Yasuda, Satoshi;
- Miyake, Nozomi;
- Ito, Takanori;
- Tanaka, Junko
Publication type:
Article
Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle‐aged patients with non‐alcoholic fatty liver disease.
Published in:
Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 11, p. 2011, doi. 10.1111/jgh.14734
By:
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Sone, Yasuhiro;
- Yasuda, Satoshi;
- Miyake, Nozomi;
- Kumada, Takashi;
- Tanaka, Junko
Publication type:
Article

Found: 7

Natural history of liver‐related disease in patients with chronic hepatitis C virus infection: An analysis using a Markov chain model.

Abnormal fucosylation of alpha‐fetoprotein in patients with nonalcoholic steatohepatitis.

Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".

Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab.

Chronological change in serum albumin as a prognostic factor in patients with hepatocellular carcinoma treated with lenvatinib: proposal of albumin simplified grading based on the modified albumin–bilirubin score (ALBS grade).

Long‐term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus–related decompensated cirrhosis.

Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle‐aged patients with non‐alcoholic fatty liver disease.